drugset / Trial / NCT03383133

Studies of Sulfur Metabolism in Humans

NCT03383133

Phase 0 Completed 1 enrolled Albert Einstein College of Medicine
NaSingle-groupOpen-labelBasic science

Summary

The study test whether the NSAID allosteric site of human sulfotransferase 1A1 (SULT1A1) is operative in humans. The study will test the effects of mefenamic acid (MEF) on the sulfonation of acetaminophen (APAP, a SULT1A1 specific substrate) and dehydroepiandrosterone (DHEA, a SULT2A1 substrate). If the allosteric site is active in vivo, MEF is predicted to result in a decrease in sulfonation of APAP (MEF inhibits SULT with high affinity (Ki = 23 nM), and to have no effect on sulfonation of the DHEA (MEF has little or no effect on SULT2A1 activity).

Timeline

Start
2018-01-11
Primary completion
2023-02-02
Completion
2023-02-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1 g Oral
Subject Dehydroepiandrosterone Other / unclassified 75 mg Oral
Subject Mefenamic acid Small molecule 0.75 g Oral

Indications

No indication recorded.